I think this is positive news for ATL1102.
The FDA isn't needing a cure to be proven before a drug is approved. It just needs to see results equal to SOC.
So as long as PER can show its drug can match or better the results of steriods it should gain approval.
Its Safety and proof of out performing steriods would help gain market share. And we have preclinical trial data that shows ATL1102 will work even when the patient has prior gene therapy.
I think this is positive news for ATL1102. The FDA isn't...
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
